Biocorrx Inc (BICX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 4 | 4 | 19 | 10 | 20 |
| Cost of Goods | N/A | 2 | 13 | 4 | 10 |
| Gross Profit | 4 | 2 | 6 | 6 | 9 |
| Operating Expenses | 1,373 | 972 | 842 | 972 | 967 |
| Operating Income | -1,369 | -969 | -823 | -962 | -947 |
| Interest Expense | 522 | 369 | 294 | 207 | 190 |
| Other Income | 657 | 100 | 148 | 301 | 214 |
| Pre-tax Income | -1,234 | -1,238 | -969 | -867 | -924 |
| Net Income Continuous | -1,234 | -1,238 | -969 | -867 | -924 |
| Minority Interests | -17 | -1 | -2 | -1 | -1 |
| Net Income | $-1,217 | $-1,237 | $-967 | $-866 | $-922 |
| EPS Basic Total Ops | -0.13 | -0.14 | -0.11 | -0.10 | -0.11 |
| EPS Basic Continuous Ops | -0.13 | -0.14 | -0.11 | -0.10 | -0.11 |
| EPS Diluted Total Ops | -0.13 | -0.14 | -0.11 | -0.10 | -0.11 |
| EPS Diluted Continuous Ops | -0.13 | -0.14 | -0.11 | -0.10 | -0.11 |
| EPS Diluted Before Non-Recurring Items | -0.13 | -0.14 | -0.11 | N/A | N/A |
| EBITDA(a) | $-981 | $-641 | $-509 | $-774 | $-781 |